The Future of Biopharma Commercialization
Access Insights Conference is the only event dedicated to the full spectrum of biopharma commercialization - from regulatory policy to strategy to execution. In a year defined by policy volatility, pricing pressure, and rising launch stakes, Access Insights bridges executive vision with the operational realities that determine financial performance and patient access.
Our expert-led sessions feature industry strategists, operators, finance leaders, and technologists delivering actionable insights tailored to your company’s size, portfolio mix, and commercialization model.
Why Attend?
Join us in October!
The Mayflower Hotel, Autograph Collection
Washington, DC | October 19 - 21, 2026
What's on the 2026 Agenda?
This year, we'll have more industry speakers, thought leaders, ecosystem partners, industry veterans, practitioners, and technologists sharing their insights – and some fun along the way!
Monday | Executive Summit
On Monday afternoon, we kick off the Access Insights Conference with a state of the state from CEO Josh Halpern, as IntegriChain celebrates 20 years of supporting biopharma manufacturers in their goals for patient access and net revenue optimization. Bill Roth will walk us through the Great Re-Pricing, examining the fragmenting market and its emerging payer realities. Attendees will gain valuable perspectives from powerhouse panels discussing the latest implications of evolving healthcare policies, market dynamics, and their impact on pricing and commercialization strategies. Industry leaders in market access will also share actionable insights on navigating today’s most pressing challenges.
Tuesday and Wednesday | Expert Panels and Hot Topics
Expert panels will deliver critical insights on three key industry shifts: navigating the regulatory landscape, the evolving three payer economy dynamics, and how agentic AI and technology will assist decisionmakers in critical decisions around data optimization and patient access in the decade ahead.
Hot Topics Tracks
Pricing, Policy, and Reimbursement: Navigating healthcare policy shifts, transitioning from affordability programs, innovating GTN modeling, ensuring IRA and 340B operational readiness,, and launch to lifecycle requirements.
Data and Technology: Leveraging AI/ML innovation, the next generation of data architecture, optimizing master data management, strengthening affordability program controls.
Business and Strategy: Transforming net revenue access in Big Pharma, navigating pre-commercialization decisions, refining commercial data strategies, adapting to evolving stakeholder economics, and optimizing portfolio mix for long-term success.
Check out all the sessions and activities on the Agenda Page.
Who Attends?
If you play a role in pharmaceutical commercialization, this conference is built for you. Whether you're a C-suite executive shaping future strategies, a VP optimizing today’s operations, or an analyst navigating the complexities of data and execution, Access Insights delivers the knowledge and network you need.
